https://www.indianpharmapost.com/boehringer-ingelheim-inpedild-phase-iii-trial-showed-encouraging-results-for-both-primary-endpoints-129662022-09-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/artemis-hospitals-opens-new-centre-daffodils-by-artemis-in-jaipur-129672022-09-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/innocare-announces-priority-review-of-orelabrutinib-for-the-treatment-of-rr-mzl-by-nmpa-129682022-09-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/balaxi-pharma-to-issue-rs-4961-crore-equity-shareswarrants-129692022-09-06T00:00:00+05:30always0.9https://www.indianpharmapost.com/aurionpro-acquires-us-based-startup-hello-patients-129702022-09-06T00:00:00+05:30always0.9